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Langerhans cells are generally regarded as members 
of an Ia+ dendritic cell system capable of potent acces-
sory cell function in immune responses. While it has 
been shown that murine Langer hans cells are bone mar-
row-derived, the ontogenic relationships among human 
Langerhans cells, other dendritic cells, macrophages, 
and leukocytes in general have yet to be fully clarified. 
Recently, several pan-leukocyte monoclonal antibodies 
have been produced which react with the human leuko-
cyte common antigen. This antigen resembles the mu-
rine T200 antigen and is expressed by all leukocyte 
subtypes but not by nonhematopoietic cells. Using an 
immunoperoxidase technique for staining suspensions 
of live skin cells, we have documented Langerhans cell 
reactivity with pan-leukocyte monoclonal antibody 
L3Bl2 at the ultrastructural level. Reactivity with this 
highly sensitive and specific pan-leukocyte marker sup-
ports the concept of the human Langerhans cell as a 
specialized form of bone marrow-derived mononuclear 
leukocyte and defines an immunologic feature common 
to dendritic cells, macrophages, and leukocytes that is 
not shared by other cell types. This finding is discussed 
in the context of other recent data concerning the im-
munologic phenotype of Langer hans cells. Since the im-
munoultrastructural method employed does not require 
cell fixation of any kind prior to immunologic staining, 
it should prove particularly useful for studying cell sur-
face antigens that are adversely affected by fixation. 
Langerhans cells are dendritic mononuclear cells containing 
characteristic Birbeck granules [1-4]. Although most com-
monly described within the epidermis, they have a rather wide 
tissue distribution including dermis, lymph node, thymus, oral 
cavity, esop hagus, vagina, and uterine cervix (4] . Together with 
other dendritic cells including cutaneous indeterminate cells 
and lymph node paracortical interdigitating reticulum cells, 
Langerhans cells are regarded as members of an Ia+ dendritic 
cell system capable of antigen processing and potent accessory 
cell function in immune responses [3,5-7]. Studies of chimeras 
have indicated that murine Langerhans cells are derived from 
bone marrow precursors [8,9]. 
The leukocyte common antigen represents a family of mole-
cules from which major bands of approximately 200,000 daltons 
can be immunoprecipitated [10-13]. Homologues exist in 
mouse, rat, and humans, including the murine T200 antigen 
[12]. These antigens are widely distributed among leukocyte 
subtypes including lymphocytes, granulocytes, monocytes, mac-
rophages, dendritic cells, and thymocytes, but are not expressed 
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by other nonhematopoietic cell types (10-13]. Recently, pan-
leukocyte monoclonal antibodies have been generated that are 
reactive with human leukocyte common antigenic determi-
nants. These include L3B12 [10], 2D1 (11], T29/33 [12], and 
F10-89-4 [13], a ll of which are sensitive and specific pan-
leukocyte markers that immunoprecipitate major bands in the 
200,000 dalton range. 
In prior investigations, we identified L3Bl2+ intraepidermal 
dendritic cells (putative Langerhans cells) in frozen sections of 
human skin (14,15]. In the present report, we have confirmed 
L3B12 reactivity with Langerhans cells at the ultrastructural 
level. This finding is discussed in the context of other recent 
data concerning the immunologic phenotype of human Langer-
hans cells. 
MATERIALS AND METHODS 
Antibodies 
The panel of murine antihuman monoclonal antibodies employed in 
this study is listed in Table l. L3Bl 2 and 2D l have been previously 
characterized [10,11]. They are pan-leukocyte reagents which immu-
noprecipitate major bands of approximately 200,000 daltons. They react 
with peripheral blood leukocytes, histiocytes, dendritic cells, thymo-
cytes, and tons ilar and nodal lymphoid cells. They do not react with 
other nonhematopoietic ce ll types. Anti-Leu-6 has been previously 
characterized as an antibody with specificity similar to OKT6 and anti-
T6 [15,16]. It reacts with a thymocyte subset and cells in dermis and 
epidermis that are T6+ and have the light microscopic features of 
Langer hans cells and indeterminate cells. Anti-Leu-M3 is a pan-histio-
cyte reagent which reacts with monocytes, tissue macrophages, and 
various dendritic cells [ l 7] . 
Jm.mu.nohistologic Staining 
Skin and lymph node biopsies were selected from the frozen t issue 
library of the Laboratory of Tissue lmmunodiagnosis at Stanford. A 
variety of inflammatory and neoplastic diseases were studied and 
yielded similar resul ts. These included mycosis fungoides, other lym-
phomas, alopecia areata, herpes simplex, and nevocellula r nev i in the 
skin and melanoma and reactive lymphoid hyperplasia in lymph nodes. 
Within a few hours of biopsy, representative unfixed portions were 
snap-frozen, cryostat-sectioned, acetone-fixed, and stained with a 
three-stage monoclonal antibody-biotin-avidin immunoperoxidase 
technique as previously described [18]. Normal peripheral blood leu-
kocytes, includi ng monocytes labeled with phagocytosed latex beads, 
were prepared as previously descr ibed [16] and stained with a similar 
immu noperoxidase technique. Various controls were employed includ-
ing cross-comparisons among the staining patte rns of the monoclonal 
antibodies, staining with one or more stages de leted, and the substitu-
tion of first-stage reagents with other monoclonal antibodies devoid of 
specificity for the target antigens. 
Identification of Cell Types at the Light Microscope Level 
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Langerhans cells were defi ned as Leu-6+ in traepidermal dendritic 
ce lls. Leu-6+ intradermal cells were considered to represent either 
Langer hans cells or indeterm inate cells. Dermal histiocytes and lymph 
node sinus histiocytes were defined as Leu-M3+ mononuclear cells with 
abundant cytoplasm. Monocytes were defined as Leu -M3+ peripheral 
blood mononuclear cells with a moderate amount of cytoplasm con-
taining phagocytosed latex beads. Lymphocytes were defined as Leu-
M3- mononuclear cells with scant cytoplasm. Granulocytes were de-
fined as leukocytes with multilobed nuclei and re latively scant cyto-
plasm which were essentially unreactive with anti-Leu-M3. 
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Immunoelectron Microscopy 
Skin was processed for immunoelectron microscopy by methods 
s imilar to those previously described [19] . Skin obtained at surgery was 
s plit-cut with a Castroviejo keratotome and trypsinized for 30 min to 
produce dispersed skin cells which were enriched for mononuclear 
leukocytes by Ficoll-Hypaque fractionation. Aliquots were stained with 
t he same immunoperoxidase technique used for frozen sections. They 
were then gluteraldehyde-fixed and routinely processed for electron 
microscopy. Normal peripheral blood mononuclear leukocytes were 
s imilar ly obta ined by Ficoll-Hypaque centrifugation, immunostained, 
a nd processed for electron microscopy. lmmunoelectron microscopy 
controls were similar to those used for frozen sections. 
RESULTS 
Immunohistology 
Frozen sections of skin and lymph node and cytocentrifuge 
preparations of peripheral blood were stained with a panel of 
monoclonal antibodies using a biotin-avidin immunoperoxidase 
technique (Table I). These reagents stained a population of 
intraepidermal dendritic cells morphologically consistent with 
Langerhans cells (Fig 1). Leukocytes other than Langerhans 
cells were also uniformly reactive with the pan-leukocyte anti-
bodies. Staining intensity varied, with granulocytes exhibiting 
the weakest reactivity and lymphocytes the strongest. Langer-
hans cells were stained with an intermediate intensity similar 
to that observed in dermal histiocytes, lymph node sinus his-
tiocytes, and peripheral blood monocytes (Table I). Nonleuko-
cytes and extracellular elements were uniformly unreactive 
with the pan-leukocyte antibodies. 
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I mmunoelectron Microscopy 
In order to confirm that pan-leukocyte antibody reacts with 
Langerhans cells, suspensions of live cells obtained from nor-
mal skin were stained with L3B12 using the same immunope-
roxidase method that had been applied to frozen sections. The 
cells were subsequently glutaraldehyde-fixed and examined by 
light and electron microscopy. All stained cells had the mor-
phologic features of either Langer hans cells or other leukocytes 
(Fig 2- 4). Conversely, all Birbeck granule-containing Langer-
hans cells were L3B12+. Stained cells exhibited flocculent, 
electron-dense DAB reaction product localized to the exterior 
aspect of the cell membrane in a uniform or somewhat beaded 
distribution along its perimeter (Fig 3, 4). Endocytosis of DAB 
reaction product was focally observed in some Langer hans cells 
(Fig 4) . No other intracellular staining was identified. 
Normal peripheral blood mononuclear leukocytes, which had 
not been trypsinized, were also stained with L3B12 and exam-
ined ultrastructurally. No qualitative or quantitative differ-
ences in the localization of the DAB reaction product could be 
discerned between similar cells in peripheral blood or skin 
preparations. 
DISCUSSION 
The immunoultrastructural data presented in this study con-
firm that pan-leukocyte monoclonal antibody L3B12 reacts 
with human Langerhans cells. The reactivity of L3B12+ Lan-
gerhans cells with 2Dl, a second pan-leukocyte monoclonal 
antibody, strongly suggests that these antibodies are recogniz-
TABLE I. Reactr:uity of monoclonal antibodies with cells in skin, lymph node, and peripheral blood 
Relative staining intens ity" 
Antibody Specificity Langerhans MonocyteR/ Non-
cells Granulocytes his tioc~.r t.es Lymphocytes leukocyt.eR 
L3Bl2* Pan-leukocyt e ++ + + + +++ 0 
2Dlt Pan-leukocyte ++ + ++ +++ 0 
Ant i-Leu-6t Thymocytes, Langer- +++ 0 0 0 0 
ha ns cells 
Ant i-Leu-M3t Pan -histiocyte 0- ++ 0 ++ 0 Ob 
Monoclonal antibodies were obtained from (*) Ronald Levy, Stanford University, (t ) Becton-Dickinson, Mountain View, California. 
• Staining intensity: 0, negative or trace; + , wea k; ++, moderate; +++, strong. 
b Weak to moderate staining of some vascular endothelial cells. 
~...... - ~ ~ ·" 
FIG 1. Cuta neous reactivity of anti-Leu-6 (A), L3Bl2 (8) and 2Dl (C). Each antibody stained an intraperiderrnal, suprabasilar dendrit ic ce ll 
population morphologically consistent with Langer hans ce lls. L3Bl2 and 2Dl also stained leukocytes infil t rating t he skin. Al though ant i-Leu-6 
stained occasional in t radermal mononuclear ce lls, int radermal staining in (A) is due primarily to endogenous peroxidase activity in mast ce lls. 
Immunoperoxidase-sta ined frozen sections with methylene blue counterstain , X 300. 
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FIG 2. Reactivi ty of L3Bl2 with epidermal cells. Reactive cells 
(arrowheads) exhibi ted a uniform or somewhat beaded pattern of cell 
membrane staining. These cells were morphologically consistent with 
Langerhans cells or various leukocytes. Unstained cells were predomi-
nantly kerat inocytes in various stages of differentiation. One micron -
thick Epon sect ion of a n immunoperoxidase-stained cell suspension 
coun terstained wi th to luidine blue, X 1200. 
FIG 3. Reactivity of L3Bl2 with Langerha ns ce lls. Detail of a Lan-
gerhans cell demonstrating dense L3Bl2+ sta ining along the ce ll mem-
brane. Below t he nucleus (N) is a cluster of cha racteristic Langer hans 
ce ll gra nules ( L ). Electron microscopic thin section stained with uranyl 
acetate and lead citrate. Bar = 1 11m. 
ing leukocytP. common antigen determinants rather than cross-
reacting with epitopes on some other membrane component. 
The ontogenic relationships among human Langer hans cells, 
other dendritic cells, and histiocytes in general have not been 
fully clarified [3,6]. The development of detailed immunophen-
Vol. 82, No. 4 
FIG 4. React ivity of L3Bl2 with Langerhans cells. Dendritic La n-
gerhans cell exhibiting L3Bl 2+ staining of the ce ll membrane both 
along and between dendritic processes (large arrowheads). This ce ll 
shows a somewhat beaded pattern of L3Bl2+ localization. There is 
focal endocytosis of the electron -dense DAB reaction product (small 
arrowheads). Port ions of two Langer hans ce ll granules (L) are present 
just beneath t he nucleus (N) . Electron microscopic thin section s tained 
with ura nyl aceta te and lead citrate. Bar = 1 11m. 
otypic profiles of these various cell types should facilitate 
further understanding of these relationships. L3B12/2D1 re-
activity is a property shared by cells of leukocytic lineage but 
not other nonhematopoietic cell types [10- 13]. Reactivity with 
Langerhans cells supports the concept of the human Langer-
hans ce ll as a specialized form of bone marrow-derived mono-
nuclear leukocyte. It also defines an immunophenotypic feature 
shared by a wide variety of dendritic cells and macrophages 
since interdigitating reticulum cells of the lymph node paracor-
tex, sinus histiocytes, tissue macrophages, and peripheral blood 
monocytes previously have been reported to be L3B12+ [10]. 
Recent data regarding the immunophenotype of Langerhans 
cells are summarized in Table II and indicate that Langerhans 
cells and macrophages share several antigenic properties. In 
addition, Langerhans cells and macrophages exhibit similar 
L3B12/2D1 staining intensity which is usually intermediate 
between that of granulocytes and lymphocytes (Table 1). This 
may reflect a similar density of the leukocyte common antigen. 
Enzyme histochemical studies of dendritic cells and macro-
phages using refined plastic section techniques also demon-
strate several similarities including coexpression of adenosine 
triphosphatase, nonspecific esterase, and acid phosphatase 
[20,21 ,30]. The accessory cell function of both cell types has 
been well documented [3- 7). In aggregate these data suggest 
that while dendritic cells and macrophages exhibit certain 
phenotypic and functional differences [3,6], they may be more 
closely related to each other than to other bone marrow-derived 
leukocyte subsets. 
In the current investigation, we have employed a tec hnique 
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TABLE II. Review of Langerhans cell im mu,nophenotype 
Antibody" 
L3812/2D l 
Anti -HLA -A,B,C 
Anti-HLA-Dr 
Anti -S lOO 
Anti -Leu-6 (T6) 
Anti -Leu-M3 
An ti-Leu-3 (T4) 
Predominate specificity 
Leukocytes 
Ma ny tissues 
Lymphocytes, histiocytes 
Neural t issues, histiocytes 
Thymocytes, La ngerhans ce lls 
Hist iocytes 
Helper T ce lls, histiocytes 
Relative intensity of 















14- 16,20,2 1 
" L a ngerhans ce lls a re unreactive with addit ional monoclonal a nt ibodies directed aga inst T-cell an t igens [Leu-1 (Tl) , Leu-2 (TS), Leu-4 (T3}, 
Leu-5 (Tll), Leu-9 (3A1)], B-ce ll a nt igens (Bl, , , K, >.), NK-cell a nt igen (Leu-7), and CALLA (J5) [20 ]. 
"See T able I fo r grading scheme. 
for immunologically staining suspensions of live skin cells 
which can t hen be examined at t he ultrastructural level. Since 
t he detection of cellular antigens is often adversely affected 
even by relat ively mild fixation protocols [31,32], the tech-
niques used in this study may provide better antigen preserva-
tion and detection than those requiring fixation prior to stain-
ing. However, since our method employs cell suspensions, it 
has the relative disadvantage of loss of architectural features . 
The mild t rypsinization required to suspend the cells has been 
shown previously not to adversely affect antigen detection at 
t he light microscopic level (19] . Similarly, we were unable to 
detect ultrastructural differences in immunoperoxidase stain-
ing between analogous cells in trypsinized skin or untrypsinized 
peripheral blood preparations. 
W e a re indebted to Eva A. Pfendt for technical ass istance, Richa rd 
Coffin and Phi l Horne for photogra phic assistance, and Ma rgaret Beers 
fo r secretar ia l assista nce. 
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